Table 3 Outcomes of studies included in review, stratified by primary and secondary measures
From: Evidence-based practice in Behçet’s disease: identifying areas of unmet need for 2014
Disease manifestation | Number of studies | |
|---|---|---|
Primary outcome | Secondary outcome | |
Ocular | 27 | 2 |
Mucocutaneous | 26 | 5 |
Rheumatoid | 8 | 8 |
Cardiovascular | 4 | 5 |
Neurological | 2 | 5 |
Other | 4 | 6 |